Results 111 to 120 of about 25,279 (271)

Distinct Lysosomal Network Protein Profiles in Parkinsonian Syndrome Cerebrospinal Fluid. [PDF]

open access: yes, 2016
BackgroundClinical diagnosis of parkinsonian syndromes like Parkinson's disease (PD), corticobasal degeneration (CBD) and progressive supranuclear palsy (PSP) is hampered by overlapping symptomatology and lack of diagnostic biomarkers, and definitive ...
Boman, Andrea   +8 more
core   +1 more source

Diagnoses behind patients with hard-to-classify tremor and normal DaT-SPECT: a clinical follow up study [PDF]

open access: yes, 2014
The [(123)I]ioflupane—a dopamine transporter radioligand—SPECT (DaT-SPECT) has proven to be useful in the differential diagnosis of tremor. Here, we investigate the diagnoses behind patients with hard-to-classify tremor and normal DaT-SPECT.
Arias Carrión, Óscar   +4 more
core   +1 more source

PET-CT imaging in a patient with progressive supranuclear palsy [PDF]

open access: yes, 2015
Hosp Beneficencia Portuguesa São Paulo, Med Imagem, BR-01323001 São Paulo, SP, BrazilUniversidade Federal de São Paulo, Dept Neurol, São Paulo, SP, BrazilHosp Coracao, São Paulo, SP, BrazilUniversidade Federal de São Paulo, Dept Neurol, São Paulo, SP ...
Amaral, Lazaro Luiz Faria do   +6 more
core   +2 more sources

Quality of life in patients with progressive supranuclear palsy: a review of literature and implications for practice

open access: yesFrontiers in Neurology
Progressive supranuclear palsy (PSP) is an atypical form of parkinsonism characterized by tauopathy, manifesting as oculomotor dysfunction, postural instability, akinesia, and cognitive/language impairments.
Michał Markiewicz   +2 more
doaj   +1 more source

Voice and Speech in Atypical Parkinsonian Disorders

open access: yesMovement Disorders Clinical Practice, EarlyView.
Background Motor speech disorders are early, common, and functionally limiting features of atypical parkinsonian disorders (APDs) such as progressive supranuclear palsy (PSP), corticobasal syndrome (CBS), and multiple system atrophy (MSA). These impairments are underrecognized and undertreated in neurology clinics.
Federico Rodriguez‐Porcel   +48 more
wiley   +1 more source

Annona muricata (graviola): toxic or therapeutic [PDF]

open access: yes, 2008
This paper examines annona muricata (graviola): toxic or ...
Gray, A.I.   +7 more
core  

Quantitative Assessment of Visible Nigrosome‐1 in Patients with Parkinson's Disease

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background The nigrosome‐1 (N1) sign on susceptibility‐weighted imaging (SWI) typically disappears in Parkinson's disease (PD), though some patients can show uni−/bilaterally preserved N1. Objective Investigating whether visible nigrosomes in PD patients differ from those of healthy subjects (HC). Methods Forty‐eight PD and 35 HC underwent 3 T‐
Maria Eugenia Caligiuri   +10 more
wiley   +1 more source

Brain Evaluation by Dual PET/CT with [18F] FDOPA and [18F] FDG in Differential Diagnosis of Parkinsonian Syndromes

open access: yesBrain Sciences
Parkinsonian syndromes are considered clinicopathological conditions that are challenging to diagnose. Molecular imaging with [18F]-FDOPA and [18F]-FDG contributes to a more accurate clinical diagnosis by evaluating presynaptic dopaminergic pathways and ...
Fabio Andrés Sinisterra Solís   +8 more
doaj   +1 more source

Late Onset Neurodegeneration with Brain-Iron Accumulation Presenting as Parkinsonism

open access: yesCase Reports in Neurological Medicine, 2012
Neurodegeneration with brain-iron accumulation (NBIA) encompasses a family of neurodegenerative disorders connected by evidence of abnormal brain iron deposition.
Robert Fekete
doaj   +1 more source

Opsoclonus‐Myoclonus‐Ataxia Syndrome Associated with Coexisting Anti‐N‐Methyl‐D‐Aspartate Receptor and Glial Fibrillary Acidic Protein Antibodies

open access: yes
Movement Disorders Clinical Practice, EarlyView.
Eriko Igami   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy